Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 886367-52-8 | MDL No. : | MFCD07375245 |
Formula : | C10H5BrF3NS | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | - |
M.W : | 308.12 g/mol | Pubchem ID : | 46911998 |
Synonyms : |
|
Num. heavy atoms : | 16 |
Num. arom. heavy atoms : | 11 |
Fraction Csp3 : | 0.1 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 60.25 |
TPSA : | 41.13 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -4.97 cm/s |
Log Po/w (iLOGP) : | 2.73 |
Log Po/w (XLOGP3) : | 4.52 |
Log Po/w (WLOGP) : | 5.74 |
Log Po/w (MLOGP) : | 3.26 |
Log Po/w (SILICOS-IT) : | 5.3 |
Consensus Log Po/w : | 4.31 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -4.97 |
Solubility : | 0.00327 mg/ml ; 0.0000106 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -5.11 |
Solubility : | 0.00242 mg/ml ; 0.00000785 mol/l |
Class : | Moderately soluble |
Log S (SILICOS-IT) : | -5.54 |
Solubility : | 0.000899 mg/ml ; 0.00000292 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.57 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
[ 41731-39-9 ]
2-Bromo-4-(trifluoromethyl)thiazole
Similarity: 0.64
[ 159870-86-7 ]
2-Chloro-6-trifluoromethylbenzothiazole
Similarity: 0.58
[ 324-32-3 ]
2-Methyl-7-(trifluoromethyl)quinoline
Similarity: 0.55
[ 777-12-8 ]
6-(Trifluoromethyl)benzo[d]thiazol-2-amine
Similarity: 0.54
[ 37148-86-0 ]
4-(4-(Trifluoromethyl)phenyl)-1H-imidazole
Similarity: 0.54
[ 41731-39-9 ]
2-Bromo-4-(trifluoromethyl)thiazole
Similarity: 0.64
[ 159870-86-7 ]
2-Chloro-6-trifluoromethylbenzothiazole
Similarity: 0.58
[ 324-32-3 ]
2-Methyl-7-(trifluoromethyl)quinoline
Similarity: 0.55
[ 777-12-8 ]
6-(Trifluoromethyl)benzo[d]thiazol-2-amine
Similarity: 0.54
[ 886370-95-2 ]
2-Bromo-4-(pyridin-3-yl)thiazole
Similarity: 0.69
[ 41731-39-9 ]
2-Bromo-4-(trifluoromethyl)thiazole
Similarity: 0.64
[ 886370-89-4 ]
2-Bromo-4-(pyridin-2-yl)thiazole
Similarity: 0.63
[ 78502-79-1 ]
2-(Bromomethyl)-4-phenylthiazole
Similarity: 0.62
[ 78502-79-1 ]
2-(Bromomethyl)-4-phenylthiazole
Similarity: 0.62
[ 34176-31-3 ]
5-Methyl-4-phenylthiazol-2-amine hydrobromide
Similarity: 0.61
[ 2103-99-3 ]
4-(4-Chlorophenyl)thiazol-2-amine
Similarity: 0.60
[ 90533-23-6 ]
4-(3-Chlorophenyl)thiazol-2-amine
Similarity: 0.60
[ 886370-95-2 ]
2-Bromo-4-(pyridin-3-yl)thiazole
Similarity: 0.69
[ 41731-39-9 ]
2-Bromo-4-(trifluoromethyl)thiazole
Similarity: 0.64
[ 886370-89-4 ]
2-Bromo-4-(pyridin-2-yl)thiazole
Similarity: 0.63